<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2819">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02726906</url>
  </required_header>
  <id_info>
    <org_study_id>AG046928</org_study_id>
    <nct_id>NCT02726906</nct_id>
  </id_info>
  <brief_title>Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study</brief_title>
  <official_title>Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of modifiable lifestyle factors including&#xD;
      exercise and healthy living on brain health. The investigators will compare 2 types of&#xD;
      interventions, moderate aerobic walking vs. healthy living education, over 6 months to&#xD;
      evaluate changes in brain health, cognition, and physical function in older adults with&#xD;
      cognitive concerns.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cognitive decline in older adults is a major public health issue. The cost of caring for&#xD;
      older adults with substantial cognitive impairment, like those with Alzheimer's Disease in&#xD;
      the US is approximately $200 billion a year, causing major societal, economic, and caregiving&#xD;
      burden. Despite great advances towards diagnosing these problems, the discovery of effective&#xD;
      treatments has been minimal. Exploring non-pharmacological interventions, such as exercise&#xD;
      and healthy living, have gained momentum. These promising, modifiable lifestyle interventions&#xD;
      have the potential for delaying disease onset and slowing decline in cognition. However, the&#xD;
      therapeutic effect of lifestyle interventions in patients with mild cognitive impairment, a&#xD;
      prime intervention period for treatment, is not well understood. Therefore, in this study,&#xD;
      the investigators will examine brain, body, and cognitive changes in older adults who engage&#xD;
      in moderate-aerobic walking or healthy living education.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Magnetic Resonance Imaging (fMRI) brain scan as a measure of brain function</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mnemonic Similarity Test as a measure of memory (cognition)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Positron Emission Tomography (PET) scan as a measure of tracer binding</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-stage treadmill test and modified physical function test as measures of physical function</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain-derived neurotropic factor (BDNF) as a measure from blood</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Aging</condition>
  <condition>Cognitive Ability, General</condition>
  <arm_group>
    <arm_group_label>Moderate-aerobic walking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will complete a 6-month home-based moderate-aerobic walking program of 150 minutes per week with the assistance of an interventionist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Living Education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive monthly topics on healthy living lifestyles for self-paced reading over 6 months with the assistance of an interventionist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Moderate-aerobic walking</intervention_name>
    <arm_group_label>Moderate-aerobic walking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Positron Emission Tomography (PET) scan</intervention_name>
    <description>Radioligand that binds to proteins using a PET/CT scanner.</description>
    <arm_group_label>Healthy Living Education</arm_group_label>
    <arm_group_label>Moderate-aerobic walking</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Healthy living education</intervention_name>
    <arm_group_label>Healthy Living Education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Physical activity monitor</intervention_name>
    <description>Wrist device that will track daily physical activity</description>
    <arm_group_label>Healthy Living Education</arm_group_label>
    <arm_group_label>Moderate-aerobic walking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female&#xD;
&#xD;
          2. English-speaking&#xD;
&#xD;
          3. 55-80 years old&#xD;
&#xD;
          4. Exhibits sedentary behavior&#xD;
&#xD;
          5. Objective cognitive impairment&#xD;
&#xD;
          6. Mini-Mental State Exam score &gt; 26&#xD;
&#xD;
          7. Perform at least 1 standard deviations below normative values on cognitive tests&#xD;
&#xD;
          8. Absence of dementia&#xD;
&#xD;
          9. Ability to complete both MRI and PET scans&#xD;
&#xD;
         10. Physically capable of completing health programs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Baseline dementia&#xD;
&#xD;
          2. History of a neurological disorder&#xD;
&#xD;
          3. Current psychiatric illness&#xD;
&#xD;
          4. Head trauma with a loss of consciousness &gt; 10 minutes&#xD;
&#xD;
          5. Severe sensory deficits&#xD;
&#xD;
          6. Substance abuse&#xD;
&#xD;
          7. Depression (GDS &lt; 8 of 15)&#xD;
&#xD;
          8. Inability to perform intervention (e.g., inability to walk without assistance)&#xD;
&#xD;
          9. Contraindications to MRI scan (e.g., pacemaker)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2022</verification_date>
  <study_first_submitted>March 28, 2016</study_first_submitted>
  <study_first_submitted_qc>March 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2016</study_first_posted>
  <last_update_submitted>February 28, 2022</last_update_submitted>
  <last_update_submitted_qc>February 28, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Judy Pa</investigator_full_name>
    <investigator_title>Assistant Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>Alzheimer's disease</keyword>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>Brain Imaging</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

